News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Paolo Tarantino: The MSK Retrospective Experience With ADC Sequencing for MBC
Paolo Tarantino/X
May 31, 2025, 14:02

Paolo Tarantino: The MSK Retrospective Experience With ADC Sequencing for MBC

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:

“The MSK retrospective experience with ADC sequencing (T-DXd -> SG or viceversa) for MBC.
Among 85 patients included, 75% had a worse PFS with the second ADC, irrespective of the sequence. Confirms multiple reports of cross resistance between topo1 ADCs.”

Title: Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan

Authors: Nicholas Mai, Miriam M. Klar Lieberman, Emanuela Ferraro, Maria Bromberg, Yuan Chen, Pedram Razavi, Shanu Modi, Sarat Chandarlapaty, Elaine M. Walsh, Joshua Z. Drago

You can read the Full Article on JCO Precision Oncology

Paolo Tarantino: The MSK Retrospective Experience With ADC Sequencing for MBC

More posts featuring Paolo Tarantino.

ADCs Breast Cancer cancer Elaine M. Walsh Emanuela Ferraro Joshua Z. Drago Maria Bromberg Miriam M. Klar Lieberman Nicholas Mai OncoDaily Oncology Paolo Tarantino Pedram Razavi Sarat Chandarlapaty Shanu Modi Yuan Chen
Special Coverage
Science
May 31, 2025, 14:02
Paolo Tarantino: The MSK Retrospective Experience With ADC Sequencing for MBC
Blog
May 31, 2025, 13:44
Sarah Sammons Highlights 77% Response Rate with Carboplatin, Bevacizumab, and PD-1 Inhibitors in TNBC Brain Metastases
Blog
May 31, 2025, 13:38
Local Evidence Post #18: Childhood Cancer Treatment Abandonment in Gondar, Ethiopia - CANCaRe Africa
Blog
May 31, 2025, 13:32
Petros Grivas: Congrats to All Conquer Cancer, the ASCO Foundation Young Investigator Awards Recipients
Blog
May 31, 2025, 13:12
Paolo Tarantino: Join a Comprehensive Symposium on the Present and Future of ADCs in Breast Oncology
Blog
May 31, 2025, 13:10
Lobular Breast Cancer IRL Advocates for Standardised Breast Density Reporting in Ireland
Science
May 31, 2025, 12:57
Sameer Rastogi Shared Early Results from SORASTOP Trial on Discontinuing Sorafenib in Desmoid Tumors
Blog
May 31, 2025, 12:52
Fumiko Ladd Chino: Seeing Friends, Colleagues, and Collaborators Who Live in Other Places is The Best Part of ASCO
Career
May 31, 2025, 12:32
Margarita Dionysiou Awarded St. Baldrick’s Fellowship for Leukemia Research - Johns Hopkins Kimmel Cancer Center
Blog
May 31, 2025, 12:22
Giselle Sholler: The Best Part about ANR is Connecting with Friends and Colleagues, New and Old
Insight
May 31, 2025, 12:13
E. Shyam P. Reddy: Researchers Identified a New Biomarker to Predict Outcomes in KRAS G12C-Mutated NSCLC
Oncolibrary
May 31, 2025, 11:53
KANDLELIT-001 Trial Demonstrates Promising Activity of MK-1084 in KRAS G12C–Mutant Colorectal Cancer at ASCO 2025